These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 20809066)

  • 41. Regular Physical Exercise Modulates Iron Homeostasis in the 5xFAD Mouse Model of Alzheimer's Disease.
    Belaya I; Kucháriková N; Górová V; Kysenius K; Hare DJ; Crouch PJ; Malm T; Atalay M; White AR; Liddell JR; Kanninen KM
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepcidin and its therapeutic potential in neurodegenerative disorders.
    Qian ZM; Ke Y
    Med Res Rev; 2020 Mar; 40(2):633-653. PubMed ID: 31471929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.
    Masaldan S; Bush AI; Devos D; Rolland AS; Moreau C
    Free Radic Biol Med; 2019 Mar; 133():221-233. PubMed ID: 30266679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iron dysregulation and Parkinson's disease.
    Andersen JK
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S47-52. PubMed ID: 15665414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial cells are critical regulators of iron transport in a model of the human blood-brain barrier.
    Chiou B; Neal EH; Bowman AB; Lippmann ES; Simpson IA; Connor JR
    J Cereb Blood Flow Metab; 2019 Nov; 39(11):2117-2131. PubMed ID: 29911470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis?
    Lee DW; Andersen JK
    J Neurochem; 2010 Jan; 112(2):332-9. PubMed ID: 20085612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proposed biochemistry of Parkinson's and Alzheimer's diseases.
    Robertson DS
    Med Hypotheses; 2017 Nov; 109():131-138. PubMed ID: 29150272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain iron transport.
    Qian ZM; Ke Y
    Biol Rev Camb Philos Soc; 2019 Oct; 94(5):1672-1684. PubMed ID: 31190441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.
    Kell DB
    Arch Toxicol; 2010 Nov; 84(11):825-89. PubMed ID: 20967426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
    Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
    Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Redox active metals in neurodegenerative diseases.
    Acevedo K; Masaldan S; Opazo CM; Bush AI
    J Biol Inorg Chem; 2019 Dec; 24(8):1141-1157. PubMed ID: 31650248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
    Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
    J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.
    Gosselet F; Saint-Pol J; Fenart L
    Biochem Biophys Res Commun; 2014 Apr; 446(3):687-91. PubMed ID: 24275140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain metabolism as a modulator of autophagy in neurodegeneration.
    Lim Y; Cho H; Kim EK
    Brain Res; 2016 Oct; 1649(Pt B):158-165. PubMed ID: 26970520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain iron pathways and their relevance to Parkinson's disease.
    Berg D; Gerlach M; Youdim MB; Double KL; Zecca L; Riederer P; Becker G
    J Neurochem; 2001 Oct; 79(2):225-36. PubMed ID: 11677250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bayesian inference for parameter estimation in lactoferrin-mediated iron transport across blood-brain barrier.
    Khan AI; Liu J; Dutta P
    Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129459. PubMed ID: 31682896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chelating agents for neurodegenerative diseases.
    Ward RJ; Dexter DT; Crichton RR
    Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of iron in the pathology of nervous system].
    Tynecka M
    Neurol Neurochir Pol; 1995; 29(3):409-17. PubMed ID: 7566416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physical Exercise-Induced Myokines in Neurodegenerative Diseases.
    Lee B; Shin M; Park Y; Won SY; Cho KS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.